15
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      SOX7 is involved in aspirin-mediated growth inhibition of human colorectal cancer cells.

      World journal of gastroenterology : WJG
      Animals, Anti-Inflammatory Agents, Non-Steroidal, pharmacology, therapeutic use, Aspirin, Cell Line, Colorectal Neoplasms, drug therapy, pathology, physiopathology, Cyclooxygenase 2, metabolism, Cyclooxygenase 2 Inhibitors, Gene Expression Regulation, drug effects, Humans, MAP Kinase Signaling System, SOXF Transcription Factors, genetics, p38 Mitogen-Activated Protein Kinases

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          To confirm the role of sex-determining region Y-box 7 (Sox7) in aspirin-mediated growth inhibition of COX-independent human colorectal cancer cells. The cell survival percentage was examined by MTT (Moto-nuclear cell direc cytotoxicity) assay. SOX7 expression was assessed by using reverse transcription-polymerase chain reaction and Western blotting. SB203580 was used to inhibit the p38MAPK signal pathway. SOX7 promoter activity was detected by Luciferase reporter assay. SOX7 was upregulated by aspirin and was involved in aspirin-mediated growth inhibition of SW480 human colorectal cancer cells. The p38MAPK pathway played a role in aspirin-induced SOX7 expression, during which the AP1 transcription factors c-Jun and c-Fos upregulated SOX7 promoter activities. SOX7 is upregulated by aspirin and is involved in aspirin-mediated growth inhibition of human colorectal cancer SW480 cells.

          Related collections

          Author and article information

          Comments

          Comment on this article